Our manufacturing expertise and experience differentiates us from other microbiome companies. We manufacture a single strain, as opposed to a consortium of strains, which allows for simpler testing and release processes. We know the biological activity of our strain making potency testing reliable and repeatable. We have been producing commercial scale cosmetic product for several years and have been able to optimize our process and protocols over time. We use the same manufacturing process to make our clinical products which are currently used in our clinical studies. To date, we have made over 200,000 bottles with timelines associated with fulfilling consumer demand as well as the demands of clinical supply. We will be supplying our upcoming Phase 3 trials from 100 liter scale and have already achieved success at 300 liter in our first try as we prepare for commercial scale . The company continues to invest in its manufacturing capabilities, including facilities, team and intellectual property.